Evaluation of the Immunogenicity, Efficacy, and Safety of BEVS-Based SCoV2 Vaccines against SARS-CoV-2 Infection in Vivo

Project: Other project

Project Details

StatusFinished
Effective start/end date10/1/20 → 3/22/21

Funding

  • Vabiotech: $160,861.00